Molecular Pharmaceutics, volume 18, issue 1, pages 461-468
New Small-Molecule Glycoconjugates of Docetaxel and GalNAc for Targeted Delivery to Hepatocellular Carcinoma
Petrov Rostislav A
1, 2
,
Mefedova Sofiia R
2
,
Yamansarov Emil Yu
2, 3
,
Maklakova Svetlana
2, 3
,
Lopatukhina Elena V.
2
,
Burenina Olga Y
4
,
Lopukhov Anton V
2
,
Kovalev Sergey
2
,
Timchenko Yury V
2
,
Ondar Evgenia E
2
,
Ivanenkov Yan
1, 5
,
Evteev Sergei A
2
,
Vaneev Alexander N.
2, 3
,
Timoshenko Roman V
3
,
Klyachko Natalia L.
2, 4
,
Erofeev Alexander V.
2, 3
,
Gorelkin Peter
2, 3
,
Majouga Alexander G.
2, 3, 6
Publication type: Journal Article
Publication date: 2020-12-02
Journal:
Molecular Pharmaceutics
Quartile SCImago
Q1
Quartile WOS
Q1
Impact factor: 4.9
ISSN: 15438384, 15438392
Drug Discovery
Pharmaceutical Science
Molecular Medicine
Abstract
In this work, we have developed covalent and low molecular weight docetaxel delivery systems based on conjugation with N-acetyl-d-galactosamine and studied their properties related to hepatocellular carcinoma cells. The resulting glycoconjugates have an excellent affinity to the asialoglycoprotein receptor (ASGPR) in the nanomolar range of concentrations and a high cytotoxicity level comparable to docetaxel. Likewise, we observed the 21-75-fold increase in water solubility in comparison with parent docetaxel and prodrug lability to intracellular conditions with half-life values from 25.5 to 42 h. We also found that the trivalent conjugate possessed selective toxicity against hepatoma cells vs control cell lines (20-35 times). The absence of such selectivity in the case of monovalent conjugates indicates the effect of ligand valency. Specific ASGPR-mediated cellular uptake of conjugates was proved in vitro using fluorescent-labeled analogues. In addition, we showed an enhanced generation of reactive oxygen species in the HepG2 cells, which could be inhibited by the natural ligand of ASGPR. Overall, the obtained results highlight the potential of ASGPR-directed cytostatic taxane drugs for selective therapy of hepatocellular carcinoma.
Citations by journals
1
2
|
|
Russian Journal of Organic Chemistry
|
Russian Journal of Organic Chemistry
2 publications, 9.52%
|
Inorganic Chemistry Frontiers
|
Inorganic Chemistry Frontiers
1 publication, 4.76%
|
RSC Medicinal Chemistry
|
RSC Medicinal Chemistry
1 publication, 4.76%
|
Journal of Nanobiotechnology
|
Journal of Nanobiotechnology
1 publication, 4.76%
|
International Journal of Molecular Sciences
|
International Journal of Molecular Sciences
1 publication, 4.76%
|
Journal of Cluster Science
|
Journal of Cluster Science
1 publication, 4.76%
|
Molecular Pharmaceutics
|
Molecular Pharmaceutics
1 publication, 4.76%
|
Journal of Medicinal Chemistry
|
Journal of Medicinal Chemistry
1 publication, 4.76%
|
European Journal of Organic Chemistry
|
European Journal of Organic Chemistry
1 publication, 4.76%
|
Advanced healthcare materials
|
Advanced healthcare materials
1 publication, 4.76%
|
Molecules
|
Molecules
1 publication, 4.76%
|
International Journal of Nanomedicine
|
International Journal of Nanomedicine
1 publication, 4.76%
|
Molecular Therapy - Nucleic Acids
|
Molecular Therapy - Nucleic Acids
1 publication, 4.76%
|
SSRN Electronic Journal
|
SSRN Electronic Journal
1 publication, 4.76%
|
Cells
|
Cells
1 publication, 4.76%
|
Moscow University Chemistry Bulletin
|
Moscow University Chemistry Bulletin
1 publication, 4.76%
|
Lomonosov chemistry journal
|
Lomonosov chemistry journal
1 publication, 4.76%
|
Colloid Journal
|
Colloid Journal
1 publication, 4.76%
|
Analytical Chemistry
|
Analytical Chemistry
1 publication, 4.76%
|
Science China Life Sciences
|
Science China Life Sciences
1 publication, 4.76%
|
1
2
|
Citations by publishers
1
2
3
4
|
|
Pleiades Publishing
|
Pleiades Publishing
4 publications, 19.05%
|
Springer Nature
|
Springer Nature
3 publications, 14.29%
|
Multidisciplinary Digital Publishing Institute (MDPI)
|
Multidisciplinary Digital Publishing Institute (MDPI)
3 publications, 14.29%
|
American Chemical Society (ACS)
|
American Chemical Society (ACS)
3 publications, 14.29%
|
Royal Society of Chemistry (RSC)
|
Royal Society of Chemistry (RSC)
2 publications, 9.52%
|
Wiley
|
Wiley
2 publications, 9.52%
|
Dove Medical Press
|
Dove Medical Press
1 publication, 4.76%
|
Elsevier
|
Elsevier
1 publication, 4.76%
|
Social Science Electronic Publishing
|
Social Science Electronic Publishing
1 publication, 4.76%
|
Moscow University Press
|
Moscow University Press
1 publication, 4.76%
|
1
2
3
4
|
- We do not take into account publications that without a DOI.
- Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
- Statistics recalculated weekly.
{"yearsCitations":{"type":"bar","data":{"show":true,"labels":[2021,2022,2023],"ids":[0,0,0],"codes":[0,0,0],"imageUrls":["","",""],"datasets":[{"label":"Citations number","data":[2,6,13],"backgroundColor":["#3B82F6","#3B82F6","#3B82F6"],"percentage":["9.52","28.57","61.9"],"barThickness":null}]},"options":{"indexAxis":"x","maintainAspectRatio":true,"scales":{"y":{"ticks":{"precision":0,"autoSkip":false,"font":{"family":"Montserrat"},"color":"#000000"}},"x":{"ticks":{"stepSize":1,"precision":0,"font":{"family":"Montserrat"},"color":"#000000"}}},"plugins":{"legend":{"position":"top","labels":{"font":{"family":"Montserrat"},"color":"#000000"}},"title":{"display":true,"text":"Citations per year","font":{"size":24,"family":"Montserrat","weight":600},"color":"#000000"}}}},"journals":{"type":"bar","data":{"show":true,"labels":["Russian Journal of Organic Chemistry","Inorganic Chemistry Frontiers","RSC Medicinal Chemistry","Journal of Nanobiotechnology","International Journal of Molecular Sciences","Journal of Cluster Science","Molecular Pharmaceutics","Journal of Medicinal Chemistry","European Journal of Organic Chemistry","Advanced healthcare materials","Molecules","International Journal of Nanomedicine","Molecular Therapy - Nucleic Acids","SSRN Electronic Journal","Cells","Moscow University Chemistry Bulletin","Lomonosov chemistry journal","Colloid Journal","Analytical Chemistry","Science China Life Sciences"],"ids":[5728,8397,26876,11794,14627,23935,19735,3673,19472,21975,1770,10956,20403,26531,25293,10010,36055,3923,18157,8991],"codes":[0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0],"imageUrls":["\/storage\/images\/resized\/oZgeErrVFhuDksyqFURLvYS1wtVSBWczh001igGo_medium.webp","\/storage\/images\/resized\/leiAYcRDGTSl5B1eCnwpSGqmDEUEfDPPoYisFGhT_medium.webp","\/storage\/images\/resized\/leiAYcRDGTSl5B1eCnwpSGqmDEUEfDPPoYisFGhT_medium.webp","\/storage\/images\/resized\/voXLqlsvTwv5p3iMQ8Dhs95nqB4AXOG7Taj7G4ra_medium.webp","\/storage\/images\/resized\/MjH1ITP7lMYGxeqUZfkt2BnVLgjkk413jwBV97XX_medium.webp","\/storage\/images\/resized\/voXLqlsvTwv5p3iMQ8Dhs95nqB4AXOG7Taj7G4ra_medium.webp","\/storage\/images\/resized\/iLiQsFqFaSEx6chlGQ5fbAwF6VYU3WWa08hkss0g_medium.webp","\/storage\/images\/resized\/iLiQsFqFaSEx6chlGQ5fbAwF6VYU3WWa08hkss0g_medium.webp","\/storage\/images\/resized\/bRyGpdm98BkAUYiK1YFNpl5Z7hPu6Gd87gbIeuG3_medium.webp","\/storage\/images\/resized\/bRyGpdm98BkAUYiK1YFNpl5Z7hPu6Gd87gbIeuG3_medium.webp","\/storage\/images\/resized\/MjH1ITP7lMYGxeqUZfkt2BnVLgjkk413jwBV97XX_medium.webp","\/storage\/images\/resized\/wVWp6zaxUsMdR03dYMdOZoesUrVGtNMWkHKByIvT_medium.webp","\/storage\/images\/resized\/GDnYOu1UpMMfMMRV6Aqle4H0YLLsraeD9IP9qScG_medium.webp","\/storage\/images\/resized\/VB6UIgqsyDBgrsTtqT4C2ImAHGDidVrMrprJV4LS_medium.webp","\/storage\/images\/resized\/MjH1ITP7lMYGxeqUZfkt2BnVLgjkk413jwBV97XX_medium.webp","\/storage\/images\/resized\/oZgeErrVFhuDksyqFURLvYS1wtVSBWczh001igGo_medium.webp","\/storage\/images\/resized\/pvlU1ac3KtgQWhw18PWQixiYpj68vOMFPdjtu7Nv_medium.webp","\/storage\/images\/resized\/oZgeErrVFhuDksyqFURLvYS1wtVSBWczh001igGo_medium.webp","\/storage\/images\/resized\/iLiQsFqFaSEx6chlGQ5fbAwF6VYU3WWa08hkss0g_medium.webp","\/storage\/images\/resized\/voXLqlsvTwv5p3iMQ8Dhs95nqB4AXOG7Taj7G4ra_medium.webp"],"datasets":[{"label":"","data":[2,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1],"backgroundColor":["#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6"],"percentage":[9.52,4.76,4.76,4.76,4.76,4.76,4.76,4.76,4.76,4.76,4.76,4.76,4.76,4.76,4.76,4.76,4.76,4.76,4.76,4.76],"barThickness":13}]},"options":{"indexAxis":"y","maintainAspectRatio":false,"scales":{"y":{"ticks":{"precision":0,"autoSkip":false,"font":{"family":"Montserrat"},"color":"#000000"}},"x":{"ticks":{"stepSize":null,"precision":0,"font":{"family":"Montserrat"},"color":"#000000"}}},"plugins":{"legend":{"position":"top","labels":{"font":{"family":"Montserrat"},"color":"#000000"}},"title":{"display":true,"text":"Journals","font":{"size":24,"family":"Montserrat","weight":600},"color":"#000000"}}}},"publishers":{"type":"bar","data":{"show":true,"labels":["Pleiades Publishing","Springer Nature","Multidisciplinary Digital Publishing Institute (MDPI)","American Chemical Society (ACS)","Royal Society of Chemistry (RSC)","Wiley","Dove Medical Press","Elsevier","Social Science Electronic Publishing","Moscow University Press"],"ids":[101,8,202,40,123,11,417,17,7090,9299],"codes":[0,0,0,0,0,0,0,0,0,0],"imageUrls":["\/storage\/images\/resized\/oZgeErrVFhuDksyqFURLvYS1wtVSBWczh001igGo_medium.webp","\/storage\/images\/resized\/voXLqlsvTwv5p3iMQ8Dhs95nqB4AXOG7Taj7G4ra_medium.webp","\/storage\/images\/resized\/MjH1ITP7lMYGxeqUZfkt2BnVLgjkk413jwBV97XX_medium.webp","\/storage\/images\/resized\/iLiQsFqFaSEx6chlGQ5fbAwF6VYU3WWa08hkss0g_medium.webp","\/storage\/images\/resized\/leiAYcRDGTSl5B1eCnwpSGqmDEUEfDPPoYisFGhT_medium.webp","\/storage\/images\/resized\/bRyGpdm98BkAUYiK1YFNpl5Z7hPu6Gd87gbIeuG3_medium.webp","\/storage\/images\/resized\/wVWp6zaxUsMdR03dYMdOZoesUrVGtNMWkHKByIvT_medium.webp","\/storage\/images\/resized\/GDnYOu1UpMMfMMRV6Aqle4H0YLLsraeD9IP9qScG_medium.webp","\/storage\/images\/resized\/VB6UIgqsyDBgrsTtqT4C2ImAHGDidVrMrprJV4LS_medium.webp","\/storage\/images\/resized\/pvlU1ac3KtgQWhw18PWQixiYpj68vOMFPdjtu7Nv_medium.webp"],"datasets":[{"label":"","data":[4,3,3,3,2,2,1,1,1,1],"backgroundColor":["#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6"],"percentage":[19.05,14.29,14.29,14.29,9.52,9.52,4.76,4.76,4.76,4.76],"barThickness":13}]},"options":{"indexAxis":"y","maintainAspectRatio":false,"scales":{"y":{"ticks":{"precision":0,"autoSkip":false,"font":{"family":"Montserrat"},"color":"#000000"}},"x":{"ticks":{"stepSize":null,"precision":0,"font":{"family":"Montserrat"},"color":"#000000"}}},"plugins":{"legend":{"position":"top","labels":{"font":{"family":"Montserrat"},"color":"#000000"}},"title":{"display":true,"text":"Publishers","font":{"size":24,"family":"Montserrat","weight":600},"color":"#000000"}}}}}
Metrics
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
GOST
Copy
Petrov R. A. et al. New Small-Molecule Glycoconjugates of Docetaxel and GalNAc for Targeted Delivery to Hepatocellular Carcinoma // Molecular Pharmaceutics. 2020. Vol. 18. No. 1. pp. 461-468.
GOST all authors (up to 50)
Copy
Petrov R. A., Mefedova S. R., Yamansarov E. Yu., Maklakova S., Grishin D. A., Lopatukhina E. V., Burenina O. Y., Lopukhov A. V., Kovalev S., Timchenko Y. V., Ondar E. E., Ivanenkov Y., Evteev S. A., Vaneev A. N., Timoshenko R. V., Klyachko N. L., Erofeev A. V., Gorelkin P., Beloglazkina E. K., Majouga A. G. New Small-Molecule Glycoconjugates of Docetaxel and GalNAc for Targeted Delivery to Hepatocellular Carcinoma // Molecular Pharmaceutics. 2020. Vol. 18. No. 1. pp. 461-468.
Cite this
RIS
Copy
TY - JOUR
DO - 10.1021/acs.molpharmaceut.0c00980
UR - https://doi.org/10.1021%2Facs.molpharmaceut.0c00980
TI - New Small-Molecule Glycoconjugates of Docetaxel and GalNAc for Targeted Delivery to Hepatocellular Carcinoma
T2 - Molecular Pharmaceutics
AU - Mefedova, Sofiia R
AU - Grishin, Dmitrii A
AU - Lopatukhina, Elena V.
AU - Ondar, Evgenia E
AU - Timoshenko, Roman V
AU - Evteev, Sergei A
AU - Petrov, Rostislav A
AU - Yamansarov, Emil Yu
AU - Maklakova, Svetlana
AU - Lopukhov, Anton V
AU - Kovalev, Sergey
AU - Ivanenkov, Yan
AU - Vaneev, Alexander N.
AU - Klyachko, Natalia L.
AU - Majouga, Alexander G.
AU - Burenina, Olga Y
AU - Timchenko, Yury V
AU - Erofeev, Alexander V.
AU - Gorelkin, Peter
AU - Beloglazkina, Elena K.
PY - 2020
DA - 2020/12/02 00:00:00
PB - American Chemical Society (ACS)
SP - 461-468
IS - 1
VL - 18
SN - 1543-8384
SN - 1543-8392
ER -
Cite this
BibTex
Copy
@article{2020_Petrov,
author = {Sofiia R Mefedova and Dmitrii A Grishin and Elena V. Lopatukhina and Evgenia E Ondar and Roman V Timoshenko and Sergei A Evteev and Rostislav A Petrov and Emil Yu Yamansarov and Svetlana Maklakova and Anton V Lopukhov and Sergey Kovalev and Yan Ivanenkov and Alexander N. Vaneev and Natalia L. Klyachko and Alexander G. Majouga and Olga Y Burenina and Yury V Timchenko and Alexander V. Erofeev and Peter Gorelkin and Elena K. Beloglazkina},
title = {New Small-Molecule Glycoconjugates of Docetaxel and GalNAc for Targeted Delivery to Hepatocellular Carcinoma},
journal = {Molecular Pharmaceutics},
year = {2020},
volume = {18},
publisher = {American Chemical Society (ACS)},
month = {dec},
url = {https://doi.org/10.1021%2Facs.molpharmaceut.0c00980},
number = {1},
pages = {461--468},
doi = {10.1021/acs.molpharmaceut.0c00980}
}
Cite this
MLA
Copy
Petrov, Rostislav A., et al. āNew Small-Molecule Glycoconjugates of Docetaxel and GalNAc for Targeted Delivery to Hepatocellular Carcinoma.ā Molecular Pharmaceutics, vol. 18, no. 1, Dec. 2020, pp. 461-468. https://doi.org/10.1021%2Facs.molpharmaceut.0c00980.